Markavyuktakshir Nasya for vyanga(melasma) patients for 15 days

Phase 2/3

Not yet recruiting

• Conditions: Other skin changes due to chronicexposure to nonionizing radiation. Ayurveda Condition: VYANGAH, (2) ICD-10 Condition: L55-L59||Radiation-related disorders of the skin and subcutaneous tissue. Ayurveda Condition: Patients having tanu niruj mandal on face chicks chin forehead ,

• Registration Number: CTRI/2023/11/060205
• Lead Sponsor: PDEAS college of ayurved and research centre Nigadi pune

Brief Summary

Nowadays beauty has its own importance.Vyanga is nothing but the discolouration of skin somehow like patches of different colours on face  which is explained by vagbhata in kshudrarogas. Under its treatment vagbhat has mentioned markavyuktakshir nasya for managing vyanga disease. The above treatment will be given to patients for 15 days and results will be noted. mainly the color changes in complexion of skin will be noted.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2023-11-15
• Study Start: 2023-11-27

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 45

Inclusion Criteria

• 1.Patients showing classical signs and symptoms of vyanga like tanu, niruja, shyava mandal on face.
• 2.Patients of age between 25 to 55 years irrespective of gender, religion and economic status.

Exclusion Criteria

• 1.Vyanga caused due to any known systemic disease like Addison’s disease, Cushing’s syndrome.
• 2.Vyanga caused since birth like Nevus of Ota 3.Vyanga along with kushta roga 4.Hyper pigmentation caused by known case of tumour like malignant melanoma 5.Pregnant and lactating women 6.Patient’s anarha for nasya karma.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To Evaluate efficacy of markavyuktakshir nasya in management of vyanga for 15 days	3 follow ups will be taken on 7th,15th and 21th day and the treatment will be given for 15 days

Secondary Outcome Measures

Name	Time	Method
To observe the adverse effect if any for 15 days	15 days study with 3 folow ups 7th, 15th and 21th day

Trial Locations

Locations (1)

Ayurved Rugnalaya and Sterling Multi Speciality Hospital Nigadi Pune; 🇮🇳 Pune, MAHARASHTRA, India

Ayurved Rugnalaya and Sterling Multi Speciality Hospital Nigadi Pune

🇮🇳Pune, MAHARASHTRA, India

Dr Shubhangi Vishwanath Maske

Principal investigator

8390388566

shubhmaske26@gmail.com